Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy

por Cao, Wan-Ting, Huang, Rong, Liu, Shan, Fan, Yi-Hong, Xu, Mao-Sheng, Xu, Yi, Ni, Hui
Publicado 2022

Predictive value of blood concentration of biologics on endoscopic inactivity in inflammatory bowel disease: A systematic review

por Cao, Wan-Ting, Huang, Rong, Jiang, Ke-Fang, Qiao, Xue-Hui, Wang, Jing-Jing, Fan, Yi-Hong, Xu, Yi
Publicado 2021